Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are ...

Since nearly the start of the pandemic, scientists have known that a Covid-19 infection increases the risk of heart problems.

Adults whose resting heart rate follows an atypical pattern as they age may face a greater risk of developing heart failure ...

Digoxin should be considered for patients who have symptoms of congestive heart failure (CHF) caused by LVSD while receiving standard therapy. ACE inhibitors rather than angiotensin-receptor ...